Skip to main content

Table 1 Patient characteristics

From: Use of a multi-drug regimen gemcitabine, 5-fluorouracil, irinotecan, cisplatin, bevacizumab, docetaxel, and cyclophosphamide (GFIP/BDC) for heavily pretreated relapsed epithelial ovarian, fallopian tube and primary peritoneal cancer

Characteristic

No. of Patients

Percentage (%)

Primary Site of Malignancy

 Ovary

17

85

 Fallopian Tube

1

5

 Peritoneal

2

10

Histologic Type

 Papillary serous

18

90

 Endometriod

1

5

 Carcinosarcoma

1

5

Histologic Grade

 G2

3

15

 G3

17

85

Stage at Initial Diagnosis

 IA

1

5

 IIIA

1

5

 IIIB

1

5

 IIIC

13

65

 IV

4

20

Primary Cytoreductive Surgery

 No gross residual

4

20

 Optimal

9

45

 Suboptimal

1

5

 Unknown

6

30